Market closed · Next open: Monday 9:30 AM ET
Last update: Nov 20, 2026, 6:14 PM ET
MetLife, Inc.
$95.67▼ 1.98% today
Market Closed

Why MetLife, Inc. (MET) stock moved

No significant move on Nov 20, 2026 (−2.0%, close-to-close). Latest notable session: Nov 5, 2026.

Latest session▼ 3.1% · Nov 5, 2026 close

Why MetLife, Inc. (MET) fell 3.1% on November 5, 2026

MetLife, Inc. (MET) fell 3.1% on November 5, 2026, closing at $99.75 versus $102.89 the prior session (close-to-close, from daily closes). After reporting Q3 2026 earnings on 2026-11-04. The company beat EPS consensus by 0.36%, reporting $2.78 vs. estimate $2.77, driven by higher investment income; however, revenue missed expectations. Source: FMP price data; BestStocks detection.

Updated
Prior close
$102.89
Nov 5, 2026 close
$99.75
Change (close-to-close)
−$3.14
−3.05%
As first detected · Nov 5, 2026, 4:42 PM ET

MetLife, Inc. (MET) moved -4.55% from $104.50 to $99.75 on 2026-11-05, the day after reporting Q3 2026 earnings on 2026-11-04. The company beat EPS consensus by 0.36%, reporting $2.78 vs. estimate $2.77, driven by higher investment income; however, revenue missed expectations.

What to watch next: MetLife's next earnings are scheduled for 2027-02-03 with a consensus EPS estimate of $2.62.

Source: FMP price data; BestStocks detection · percentages in this note are as captured at detection; the confirmed close-to-close move is shown above.

Earlier sessions that moved MET

  1. −4.6%We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found.
  2. +2.8%No breaking news catalyst was identified; the advance may reflect positioning ahead of the company's Q3 2026 earnings announcement scheduled for November 4, 2026 after market close (Business Wire, October 7).

MetLife, Inc. (MET) shares fell 2.0% to $95.67 as of November 21, 2026, a modest decline from the prior close of $97.60. BestStocks flagged the session as a major change for MET. The move is tied to company news. Below, we break down what changed for MET, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

Company News

MetLife Investment Management closed a $370 million opportunistic real estate debt fund, expanding its institutional asset management capabilities. Fund closure demonstrates MIM's growth in alternative assets, potentially diversifying MET's revenue streams beyond traditional insurance operations.

This summary describes the catalyst and move as first detected on Nov 17, 2026, 10:18 AM EST; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
NewsLow confidence
Rel. volume
1.3×
Normal
Vs peers
—
No comparable peers
Market cap
$60.1B
New York Stock Exchange
Analyst target
$109
+13.7% vs price
Price chart
Oct 21 – Nov 20
NNFNNNFFF$95$100$104Oct 21Oct 29Nov 5Nov 13Nov 20
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for MetLife, Inc. investors

For MetLife, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Negative session, down 2.0%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $108.78, implying +13.7% upside from $95.67. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality low (46/100). With earnings roughly 74 days out, the next report is the most likely near-term test of the move.

MET price reaction

MET last traded at $95.67, down $1.93 (-1.98%) from the previous close of $97.60. The session traded on 1.3× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $95.67 and $103.57, and it currently sits about 0% of the way up that band.

Bullish and bearish analyst opinions on MetLife, Inc. (MET)

Latest catalysta bearish counterpoint
The latest catalyst — negative company news — a bearish counterpoint that challenges the prevailing bullish analyst view.

The consensus analyst price target on MetLife, Inc. (MET) is $108.78, 13.7% above the recent $95.67. Over the past 90 days analysts logged 1 upgrade, 11 maintains, and 0 downgrades. Here is how the bullish and bearish cases on MET line up.

The bullish case

  • Wall Street's consensus price target of $108.78 implies +13.7% upside from $95.67.
  • The Street's most bullish target is $112.00 (+17.1%).
  • 1 analyst upgrade in the past 90 days, most recently Piper Sandler to Overweight (2026-09-22).
  • Positive price momentum.

The bearish case

  • Negative session, down 2.0%.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Nov 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $109+13.7%
↑ 1 upgrades= 11 maintains
Wells Fargo maintained Overweight · 2026-11-12
SEC filings watch
8-K2026-11-16
Material event — review for impact
high
8-K2026-11-10
Material event — review for impact
high
10-Q2026-11-06
Quarterly financial results
medium
8-K2026-11-04
Material event — review for impact
high
Peer context
MET-2.0%

Previous notable changes for MET

News2026-11-19-2.2%
MetLife presented at J.P. Morgan European Financials Conference, discussing strategic and operational insights.
News2026-11-16-1.2%
MetLife declared $0.32584066 quarterly dividend on Series A floating rate preferred stock.
Filings2026-11-16-1.2%
MetLife, Inc. (MET) filed a new 8-K on November 16, 2026. The specific content of the filing was not disclosed in available summaries.
News2026-11-15
Diversified Trust Co increased MetLife stake by 27.2% to 30,028 shares in Q3.
Upcoming catalysts & outlook
Next earnings
2027-02-03 (est.)
in 74 days
10-Q Filing (est.)
2027-02-05
Medium impact
Thesis shift
Neutral / Mixed
bearish signal
Risk level
Low
from change events

Frequently asked questions about MET

Why did MetLife, Inc. (MET) stock move?

MetLife, Inc. (MET) fell 3.1% on November 5, 2026, closing at $99.75 versus $102.89 the prior session (close-to-close, from daily closes). After reporting Q3 2026 earnings on 2026-11-04. The company beat EPS consensus by 0.36%, reporting $2.78 vs. estimate $2.77, driven by higher investment income; however, revenue missed expectations. Source: FMP price data; BestStocks detection.

How much did MET stock fall?

MET lost 1.98% ($1.93) versus the prior close of $97.60, last trading at $95.67 on 1.3× average volume.

When is MetLife, Inc.'s next earnings date?

MET's next earnings report is estimated for 2027-02-03 — about 74 days away.

What is the analyst price target for MET?

The consensus analyst price target for MET is $108.78, about 13.7% above the current $95.67. Over the past 90 days, analysts recorded 1 upgrade, 11 maintains, and 0 downgrades.

How BestStocks tracks MET

This page is generated automatically by BestStocks' change-detection system after company news was detected and verified against independent data sources. It draws on 20 tracked change events for MET, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of November 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.